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New tools (specific antibodies/inhibitor, CRISPR/Cas9 (clus-
tered regularly interspaced short palindromic repeats/Cas9)
knock-out, improved functional assay) allowed re-evaluation
of 30,50-cyclicadenosine monophosphate (cAMP) regulation of
SLC26A3 down-regulated in adenoma (DRA). cAMP stimu-
lates DRA activity in human embryonic kidney 293
(HEK293)/DRA cells, Caco-2 cells, and human colonoids in a
cystic fibrosis transmembrane conductance regulator
(CFTR)–dependent manner that does not require CFTR
transport activity.
BACKGROUND & AIMS: SLC26A3 (DRA) is an electroneutral
Cl-/HCO3
- exchanger that is present in the apical domain of mul-
tiple intestinal segments. An area that has continued to be poorly
understood is related to DRA regulation in acute adenosine 30,50-
cyclic monophosphate (cAMP)-related diarrheas, in which DRA
appears to be both inhibited as part of NaCl absorption and
stimulated to contribute to increased HCO3
- secretion. Different
cell models expressing DRA have shown that cAMP inhibits,
stimulates, or does not affect its activity.
METHODS: This study re-evaluated cAMP regulation of DRA
using new tools, including a successful knockout cell model, a
specific DRA inhibitor (DRAinh-A250), specific antibodies, and a
transport assay that did not rely on nonspecific inhibitors. The
studies compared DRA regulation in colonoids made from
normal human colon with regulation in the colon cancer cell
line, Caco-2.
RESULTS: DRA is an apical protein in human proximal colon,
differentiated colonoid monolayers, and Caco-2 cells. It is
glycosylated and appears as 2 bands. cAMP (forskolin)
acutely stimulated DRA activity in human colonoids and
Caco-2 cells. In these cells, DRA is the predominant apical
Cl-/HCO3
- exchanger and is inhibited by DRAinh-A250 with a
median inhibitory concentration of 0.5 and 0.2 mmol/L,
respectively. However, there was no effect of cAMP in
HEK293/DRA cells that lacked a cystic fibrosis trans-
membrane conductance regulator (CFTR). When CFTR was
expressed in HEK293/DRA cells, cAMP also stimulated DRA
activity. In all cases, cAMP stimulation of DRA was not
inhibited by CFTRinh-172.CONCLUSIONS: DRA is acutely stimulated by cAMP by a pro-
cess that is CFTR-dependent, but appears to be one of multiple
regulatory effects of CFTR that does not require CFTR activity.
(Cell Mol Gastroenterol Hepatol 2019;7:641–653; https://
doi.org/10.1016/j.jcmgh.2019.01.002)
Keywords: Cl-/HCO3
- Exchange; CFTR; Colon; Secretory
Diarrhea; Enteroids.
here is a long-standing unexplained aspect of theTregulation of intestinal electrolyte transport with
relevance to the pathophysiology of diarrhea. This relates to
acute regulation of SLC26A3 down-regulated in adenoma
(DRA) activity. It has been established that DRA is a Cl-/
HCO3
- exchanger that takes part in both intestinal Cl- ab-
sorption and HCO3
- secretion. DRA is expressed differen-
tially along the human intestinal horizontal axis, with
maximum expression in the colon > ileum > duodenum >>
jejunum. This is consistent with the role for DRA in ileal and
proximal colonic neutral NaCl absorption, in which it is
linked to Naþ/Hþ exchanger 3 (NHE3) and performs
Cl- absorption. DRA also is part of the anion secretory
process, accounting for a component of adenosine 30,50-
cyclic monophosphate (cAMP)-stimulated intestinal HCO3
-
secretion.1–4
In cAMP/cholera toxin–related diarrheas, there is both
inhibition of neutral NaCl absorption and stimulation of Cl-
and HCO3
- secretion.5–8 It has never been explained how
DRA can be both inhibited and stimulated at the same time
642 Tse et al Cellular and Molecular Gastroenterology and Hepatology Vol. 7, No. 3in cAMP-related diarrhea. Attempts to study cAMP effects
on DRA activity in cell-based systems have not been able to
answer this question and reported cAMP regulation of DRA
is contradictory based on the cell type studied. In HEK293/
DRA cells and oocytes, there was no cAMP effect unless the
cystic fibrosis transmembrane conductance regulator
(CFTR) also was expressed, which led to modest stimula-
tion.9,10 In Caco-2 cells, cAMP inhibited DRA activity using
36Cl to measure unidirectional fluxes, which was accompa-
nied by less brush-border DRA.11 In murine duodenal
brush-border vesicle studies, cAMP increased Cl-/HCO3
-
exchange.12 Most insights concerning basal and cAMP
regulation of DRA have come from in vivo mouse studies.
Under basal conditions, when NHE3 is present and active,
DRA performs net Cl- absorption and some HCO3
- secretion,
whereas if NHE3 is absent or inhibited, DRA performs
increased HCO3
- secretion but only if CFTR is present.2,13,14
DRA-mediated HCO3
- secretion was stimulated by cAMP in
mouse duodenum and colon,3,4 and the residual HCO3
-
secretion in DRA-knockout (KO) mice was not sensitive to
cAMP.4 A major gap relevant to understanding human
diarrheal disease pathophysiology is that these questions
have not been asked in normal human intestine, specifically
in the intestinal segments in which most linked NaCl
absorption occurs: the ileum and proximal colon.15,16
Understanding how DRA is regulated by cAMP is espe-
cially important because intestinal HCO3
- is lost in severe
diarrheas, and despite inclusion of HCO3
-/citrate in World
Health Organization oral rehydration salts solution, the
acidosis of severe diarrheas often is inadequately corrected.
Because of the recent availability of multiple new and
underused cell systems and specific tools for understanding
DRA regulation, we have re-examined the acute effect of
cAMP on DRA activity using normal human colonoids, in
comparison with the widely used polarized human colon
cancer cell line, Caco-2 cells. Colonoids are an ex vivo, self-
perpetuating, primary cultured normal human colonic stem
cell–derived model that can be grown as monolayers and
studied in either an undifferentiated or crypt-like state or a
differentiated or surface-like state.17 Colonoid monolayers
from normal human proximal colon were studied because
this is a segment in which significant amounts of neutral
NaCl absorption occurs along with anion secretion.
Results
DRA Is Expressed in Caco-2 Cells, Proximal
Colonoids, and Human Proximal Colon With
Increased Expression With Differentiation
DRA was identified with a commercially available anti-
body in polarized Caco-2 cells grown on Transwell inserts
as a protein with 2 bands: one band of >102 kilodaltons and
one band of >76 kilodaltons (Figure 1A), as previously
reported.18 The specificity of this antibody was supported
by clustered regularly interspaced short palindromic re-
peats/Cas9 (CRISPR/Cas9) KO in Caco-2 cells (Figure 1A
and B). In addition, although HEK293 cells do not express
DRA endogenously, transfection of human DRA showed the
same 2 bands.18 In addition, we previously reported thatdeglycoslyation of DRA by Peptide:N-glycosidase F (PNGase
F) in HEK293/DRA cells and differentiated duodenal
enteroids caused both DRA bands to decrease to a common
molecular weight just below 76 kilodaltons.18 Furthermore,
DRA expression increases with differentiation, as illustrated
in Caco-2 cells grown on semipermeable supports. This is
shown in Figure 1C, with a lack of significant DRA expres-
sion 4 days after confluency, with increasing expression
until days 14 to 18.
In human proximal colonoids, DRA expression also greatly
increased in differentiated cells (5 days after wingless-related
integration site 3A [WNT3A] removal) compared with un-
differentiated cells (grown in the presence of WNT3A)
(Figure 1D). This occurred at least in part transcriptionally, as
we previously reported, with an increase in DRA messenger
RNA of 21-fold upon differentiation of duodenal enteroids
determined by quantitative reverse-transcription polymerase
chain reaction.18 In addition, differentiated proximal colo-
noids had apical and subapical DRA expression, which was
much greater than the expression in undifferentiated prox-
imal colonoids (not shown) (Figure 1E).
The increased DRA expression in differentiated proximal
colonoids modeled the expression in normal human colon.
Immunofluorescence of the normal human proximal colon
showed increased DRA expression in the colonic surface and
upper crypt compared with the lower crypt (Figure 1F).Cl-/HCO3
- Exchange Activity in Proximal
Colonoids and Caco-2 Cells Is Predominantly via
SLC26A3 (DRA) and Not SLC26A6 Putative
Anion Transporter-1
DRA activity was quantified as extracellular Cl- removal-




- exchange) and inhibitors of other acid-
base altering transporters, particularly the NHEs. DRA-
transfected HEK293 cells showed an immediate initiation
of alkalinization with removal of extracellular Cl-
(Figures 2A and D, and 3A), whereas untransfected cells had
minimal alkalinization (Figure 2D).
Similar rapidly initiated alkalinization after apical Cl-
removal occurred when this assay was applied to Caco-2
cells (21 days after confluency) (Figures 2B and 3B). This
alkalinization was not present in Caco-2 cells in which DRA
was knocked out by CRISPR/Cas9 (Figure 2E). In addition,
this alkalinization was not affected by the addition of
disodium 4,40-diisothiocyanatostilbene-2,20-disulfonate
(DIDS) (100 mmol/L) to the basolateral side (Figure 2F).
DRA activity also was present and measurable by the
apical Cl- removal assay in differentiated human colonoid
monolayers (Figures 2C and 3C). In all 3 cell types, addition
back of Cl- to reverse the Cl- gradient (apically for Caco-2
and colonoids) rapidly acidified the cells to an intracel-
lular pH (pHi) close to the initial pHi (Figure 2A–C). In all 3
cell types, multiple cycles of removing and adding Cl- back
were performed and at least 2 and usually 3 cycles of Cl-
removal/re-addition led to very similar initial rates of
alkalinization/acidification (Figure 2A–C). This allowed the
use of a single monolayer to determine basal and acutely
Figure 1. Protein expression of DRA increases in postconfluent Caco-2 cells and differentiated colonoids. (A) Immu-
noblotting of DRA was performed using the mouse monoclonal antibody from Santa Cruz (sc-376187). Two bands of DRA
were detected in wild-type Caco-2 cells, whereas no band was identified in DRA-KO Caco-2 cells edited by CRISPR/Cas9. (B)
Representative immunofluorescence results showing that DRA protein was detected in wild-type Caco-2 cells but not in DRA-
KO Caco-2 cells. (C) In Caco-2 cells that were grown on Transwell inserts, the protein expression of DRA was increased over
time after cells reached confluency. (D) Human colonoids were grown on Transwell inserts and differentiated for 5 days. The
protein expression of DRA was studied in paired differentiated (DF) and undifferentiated (UD) colonoid monolayers and
quantitated using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as the loading control. DRA protein expression was
6.8 ± 1.5 times higher in differentiated colonoids than undifferentiated colonoids (n ¼ 3). (E) Representative immunofluores-
cence results showing that DRA protein was located mostly on the apical membrane in postconfluent Caco-2 and differen-
tiated colonoid monolayers. Red, DRA; blue, Hoechst. Similar results were seen in 2 repeated experiments. XZ scans are
shown including the DRA-KO in Caco-2 cells. (F and G) Representative immunofluorescence results showing the localization
of (F) DRA and (G) CFTR in human proximal colon. Images were obtained from the atlas of intestinal transport (https://www.
jrturnerlab.com/Transporter-Images). Similar results were seen in histologic sections from more than 3 normal subjects for
both DRA and CFTR.
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apical Cl- removal/re-addition.
Specificity of the assay for DRA activity was established
by 2 methods, with the major concern being whether the
other SLC26A family member expressed throughout the
human gastrointestinal tract, SLC26A6 putative anion
transporter-1 (PAT-1), was present and accounted for some
or all of the Cl- removal-related alkalinization. The anion,
sulfate is transported by PAT-1, but not DRA19; thus,
whether sulfate could acidify cells when sulfate replaced Cl-
in Cl- solution was considered a contribution of PAT-1 and
not DRA. As shown in Figure 3 in HEK293/DRA cells, Caco-2
cells, and differentiated colonoids, applying a sulfategradient did not acidify pHi, although then adding Cl
-
(apically for Caco-2 and colonoid monolayers) in the same
cells induced rapid intracellular acidification. This finding
suggests that these cells showed minimal SO4
2-/HCO3
- ex-
change and supports that PAT-1 is not a significant
contributor to the Cl-/HCO3
- exchange assays in these 3 cell
types. In addition, we used a newly described small-
molecule DRA inhibitor, DRAinh-A250, which lacks effects
on other members of the SLC26A family as a second method
to determine the specificity of the DRA assay. Inhibition of
DRA by DRAinh-A250 was reversible, with a median inhibi-
tory concentration (IC50) reported in Fischer rat thyroid
(FRT)/DRA cells of approximately 0.2 mmol/L.20 This
Figure 2. Validation of Cl-/HCO3
- exchange functional assay. (A–C) Cl-/HCO3
- exchange activity was determined in (A)
HEK293/DRA cells, (B) Caco-2 monolayers, and (C) colonoid monolayers. A rapid intracellular alkalinization was observed after
the removal of extracellular Cl-, and a rapid intracellular acidification occurred after the replenishment of extracellular Cl-.
Multiple cycles of removing and replenishing extracellular Cl- were performed in a single sample. Compared with the first cycle,
the second cycle gave a very similar rate of intracellular alkalinization (HEK293/DRA, 100% ± 9%, n ¼ 11; Caco-2, 99% ± 5%,
n ¼ 7; colonoids, 103% ± 4%, n ¼ 13). (D) The initial rate of intracellular alkalinization after extracellular Cl- removal was greater
in HEK cells expressing DRA (0.63 ± 0.10/min, n ¼ 13) than wild-type HEK cells (0.05 ± 0/min, n ¼ 13). The endogenous
alkalinization in wild-type HEK cells contributed to only a small percentage (8%) of alkalinization in HEK293/DRA cells. (E)
Postconfluent Caco-2 cells showed endogenous Cl-/HCO3
- exchange activity, whereas DRA-knockout Caco-2 cells had no
detectable Cl-/HCO3
- exchange activity. n ¼ 3 for each. (F) The addition of DIDS (100 mmol/L) to the basolateral side caused no
change in the apical Cl-/HCO3
- exchange activity in Caco-2 cells (92% ± 12%, n ¼ 3). AP, apical; BL, basolateral.
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Caco-2 cells, and human colonoids (Figure 4A–C). In
HEK293/DRA cells, Caco-2 cells, and colonoids, the IC50 was
determined as 0.12 ± 0.04 mmol/L, 0.53 ± 0.10 mmol/L, and
0.22 ± 0.08 mmol/L, respectively (n ¼ 3 for each). These
studies indicated that apical Cl-/HCO3
- exchange activity in
HEK293/DRA, Caco-2, and proximal colonoids was almost
entirely caused by DRA activity.cAMP Rapidly Stimulates DRA by a
CFTR-Dependent Process That Does Not
Require CFTR Activity
To determine whether cAMP acutely affects DRA activity,
studies were performed in HEK293 and Caco-2 cells and in
human colonoid monolayers. Initial studies were performed
in HEK293 cells that stably express human DRA but do not
express CFTR endogenously.9,21 DRA activity was presentbut exposure to forskolin (10 mmol/L, 10 min) did not alter
DRA activity (Figure 5A and B).
Similar studies were performed in Caco-2 cells and
human colonoids. Results were different; as shown in
Figure 5C and D, forskolin (10 mmol/L, 10 min) caused acute
stimulation of DRA activity in both Caco-2 and colonoid
monolayers. It was further determined whether cAMP-
dependent stimulation of DRA was associated with stimu-
lation of DRA trafficking. This was performed by cell surface
biotinylation. Forskolin (10 mmol/L, 30 min) significantly
increased total DRA cell surface expression (22.5% ± 4.8%)
in Caco-2 cells (Figure 6A and B). The surface-to-total ratio
of the higher molecular weight highly glycosylated band
showed a significant increase with forskolin (27.6% ±
3.2%), while the core glycosylated band did not significantly
change (4.3% ± 2.2%). Similar studies of cell surface bio-
tinylation of DRA 10 minutes after forskolin had a slightly,
but not significantly, greater increase in total DRA surface
Figure 3. Cl-/HCO3





- exchange activity was studied using a SO4
2--based superfusate that does not contain Cl-. In these experiments,
the NHE3 inhibitor tenapanor (provided by Ardelyx, Inc, Fremont, CA) and the NHE1 and NHE2 inhibitor HOE-694 (provided by
Jorgen Peunter, Sanofi) were used in lieu of amiloride in the SO4




- exchange activity was detected in (A) HEK293/DRA cells, (B) Caco-2 monolayers, or (C) colonoid
monolayers, suggesting the process of Cl-/HCO3
- exchange in these cell models was performed by an ion transporter that is
not able to perform SO4
2-/HCO3
- exchange. These experiments were repeated at least 3 times and similar results were found in
each experiment. AP, apical; BL, basolateral.
2019 cAMP Stimulates SLC26A3 Activity 645expression (36.7% ± 7.3%; n ¼ 3). Similar changes in DRA
surface expression after forskolin were demonstrated using
immunofluorescence in Caco-2 cells (Figure 6C–E). Because
the presence of CFTR in oocytes was sufficient for cAMP
stimulation in DRA activity to occur,10 it was determined
whether forskolin stimulated DRA activity in HEK293/DRA
cells that expressed CFTR. HEK293 cells do not endoge-
nously express CFTR.21 Lipofectamine transfection was used
to transiently express GFP-CFTR and more than 90% of cells
expressed GFP-CFTR after transfection as confirmed by
microscopic observation using a Keyence BZ-X700 fluores-
cence microscope (Itasca, IL). Forskolin stimulated DRAFigure 4. Effect of DRA inhibitor on Cl-/HCO3
- exchange. (A–
(B) Caco-2 monolayers, and (C) colonoid monolayers was most
apical and basolateral), indicating that DRA is the major Cl-/HCOactivity in HEK293/DRA cells transfected with CFTR
(Figure 7A). CFTR transports HCO3
-, with a lower perme-
ability compared with Cl-, but there is increasing HCO3
-
permeability at least in some cell types with intracellular Cl-
depletion, as initially occurs with cAMP-stimulated Cl-
secretion.22 Consequently, we considered whether the
CFTR/forskolin-dependent increase in intracellular alkalin-
ization after Cl- removal could be owing to CFTR trans-
porting HCO3
-. This was examined by studying the forskolin
effect on DRA activity in HEK293/DRA/CFTR cells when
CFTR activity was inhibited using the CFTR inhibitor
CFTRinh-172. CFTRinh-172 did not alter either the basal DRAC) The Cl-/HCO3
- exchange activity in (A) HEK293/DRA cells,
ly abolished by a novel DRA inhibitor, DRAinh-A250 (5 mmol/L,
3
- exchanger in these 3 cell types. AP, apical; BL, basolateral.
Figure 5. Forskolin stimulates DRA activity in Caco-2 and human colonoids but not in HEK293/DRA cells. (A and B)
Forskolin (FSK) did not change the DRA activity in HEK293/DRA cells (n ¼ 6). (C and D) Representative traces showing that
forskolin stimulates DRA activity in (C) Caco-2 monolayers and (D) colonoid monolayers. Quantitation of the change in DRA
activity by forskolin in Caco-2 cells and colonoids is shown in Figure 8. AP, apical; BL, basolateral.
646 Tse et al Cellular and Molecular Gastroenterology and Hepatology Vol. 7, No. 3activity in HEK293/DRA cells, or the forskolin stimulation of
DRA activity in HEK293/DRA/CFTR cells measured as Cl-
removal-stimulated alkalinization (Figure 7). This shows
that cAMP stimulation of DRA requires CFTR but does not
require CFTR transport activity.
Caco-2 cells are known to express CFTR. Similarly,
immunofluorescence of differentiated human proximal
colonoids showed expression of CFTR as well as DRA in the
apical domain (Figure 1F and G). Similar studies to those in
HEK cells determined whether CFTR activity was necessary
for forskolin stimulation of DRA in Caco-2 cells and human
colonoids. Inhibiting CFTR with CFTRinh-172 did not affect
forskolin stimulation of DRA activity in either Caco-2 cells
(Figure 8A–C) or colonoids (Figure 8D–F).Discussion
DRA is a glycoprotein, both when exogenously expressed
in HEK293 cells and Chinese hamster ovary (CHO) cells or
endogenously expressed in mouse intestine.23–26 Its
molecular size as shown by Western blot varies and this is
probably owing to heterogenous glycosylation in different
cell systems and animal species.23–27 We report here that
human DRA in HEK293/DRA cells, Caco-2 cells, and differ-
entiated proximal colonoids appears as 2 bands: the upper
band is slightly higher than 102 kilodaltons and the lower
band is slightly higher than 76 kilodaltons, and, as previ-
ously shown, both of these bands are glycosylated.18 The
distribution of DRA throughout the human gastrointestinal
tract both horizontally and vertically has been described. It
is widely believed that DRA functions as a Cl-/HCO3
-
exchanger with 1:1 stoichiometry,28 but controversy exists
and some results have indicated that its transport in mice is
electrogenic and it can function as an uncoupled anion
conductance at low Cl.9 In addition, there continues to be
confusion relating to its acute regulation, particularly in
digestive physiology and in the pathophysiology of cAMP-
driven secretory diarrheal diseases. The current study was
performed to re-evaluate acute regulation of DRA based on
the availability of new normal human colonoid models thatare segment-specific, allowing what occurs in the human
proximal colon to be examined. The proximal colon was
selected for study because it is the site of high DRA
expression and is known to be the site of a large amount of
Naþ absorption, specifically neutral NaCl absorption, and
also of anion secretion, both processes in which DRA has
been implicated. Importantly, the ability to study only
epithelial cells in the stem cell–derived colonoids
allows better control of transport regulation. In addition,
studying differentiated colonoids as monolayers, which
represent the upper crypt and surface cells compared with
undifferentiated colonoids representing the lower crypt,
allowed concentration on the proximal colonic cells with the
highest DRA expression with results not diluted by lower-
expressing cells. This study also re-evaluated acute regula-
tion of DRA because there are more specific tools than what
have been available previously that include a DRA-specific,
small-molecule inhibitor (DRAinh-A250), and DRA-KO by
CRISPR/Cas9, as well as antibody validated by KO and
expression in null cells; an assay of DRA activity that does
not rely on nonspecific antagonists, such as DIDS or niflumic
acid; and, finally, an assay measuring Cl-/HCO3
- exchange
instead of hydroxide/iodide exchange because hydroxide
ion may not be an adequate substrate of DRA.29
Emphasis was on DRA regulation by increased cAMP
because of the importance of both inhibition of neutral NaCl
absorption and stimulation of active anion secretion in
secretory but noninflammatory diarrheas. Both processes
occur in the proximal colon and examples of DRA regulation
in diarrhea models in this segment have been reported,
including salmonella in which DRA message and protein are
reduced, and enteropathogenic E coli (EPEC), in which
surface expression is reduced.30,31 There also have been
inconsistent previous reports of cAMP effects on DRA ac-
tivity in multiple cell models as reviewed in the introduction
section of this article, and some segment-specific differences
described for mouse intestine. In mouse duodenum, for-
skolin stimulates HCO3
- secretion by a DRA-dependent
process that also requires CFTR including CFTR activity.2,3
In mid-distal mouse colon, in which a large amount of
Figure 6. Forskolin (FSK) increases the surface amount of DRA protein in Caco-2 cells. (A and B) The surface expression
of DRA protein was studied by surface biotinylation. Forskolin (10 mmol/L, apical and basolateral, 30 min) caused an increase in
the percentage of surface amount without changing the total amount of DRA protein in postconfluent Caco-2 monolayers.
Quantitation was performed by comparing forskolin-treated and untreated control samples with controls in each experiment
set as 100% (n ¼ 4). (C–E) Representative immunofluorescence results showing an increased amount of DRA protein in the
apical domain of polarized proximal colonoid cells after forskolin treatment (10 mmol/L, apical and basolateral, 10 min). Each
panel shows XZ projection. Quantification of the DRA intensity in control and forskolin-treated monolayers was performed with
Volocity Software (PerkinElmer, Waltham, MA). (D) The total DRA amount was not increased with forskolin treatment.
Quantification of the percentage of apical DRA in the juxta-apical region (stacks 1–3, each stack 1-mm XZ dimension, 20–25
mm total cell height) was normalized to total DRA (whole image) expression set as 100% for each experiment. At least 3
separate images and 4 random individual areas (Z sections) were analyzed for each group. Scale bar: 10 um. Results are
means ± SEM. P values are a comparison with the untreated control (n ¼ 3).
2019 cAMP Stimulates SLC26A3 Activity 647DRA is expressed, basal HCO3
- secretion was DRA-
dependent but CFTR-independent; however, with forskolin
stimulation, the increased HCO3
- secretion was dependent
on CFTR.32
The finding presented here is that in both Caco-2 cells
and human proximal colonic enteroids, forskolin stimulates
DRA activity by a CFTR-dependent process, which is similar
to what occurs in the mouse duodenum and mid-distal
colon.3,4 Forskolin/cAMP did not directly activate DRA
because its stimulatory effect occurred in HEK293/
DRA/CFTR cells, but not HEK293/DRA cells. In addition,
CFTRinh-172 had no effect on forskolin stimulation of DRA
activity, suggesting that the increased rate of intracellular
alkalinization in the presence of forskolin was not due todirect secretion of HCO3
- via CFTR in our assay. This rep-
resents another example of the regulatory function of CFTR
that does not require the transport function of CFTR.33 The
current study concentrated only on human proximal colo-
noids that were differentiated and thus represented surface
and upper crypt epithelial cells. Similarly, we showed by
immunofluorescence that intact normal human proximal
colon upper crypt and surface epithelial cells contained both
CFTR and DRA. Moreover, the forskolin stimulation was
associated with increased surface DRA, supporting the
involvement of trafficking or increased plasma membrane
stability in the mechanism of the cAMP stimulation of DRA.
However, the fact that cAMP stimulated DRA activity with a
higher percentage increase than it increased surface DRA
Figure 7. Expression of CFTR in HEK293/DRA cells reconstitutes the stimulatory effect of forskolin (FSK) on DRA
activity, which is independent of CFTR function. (A) DRA activity was determined in HEK293/DRA cells as well as HEK293/
DRA cells that were transiently transfected with CFTR, using superfusate that contained forskolin (10 mmol/L) and/or CFTRinh-
172 (5 mmol/L). Data were normalized to that of HEK293/DRA cells under basal condition (set as 100%). A stimulatory effect of
forskolin on DRA activity was observed in CFTR-expressing cells, and the stimulation was not affected by inhibiting CFTR
activity using CFTRinh-172. The number of experiments is shown as n. P values are shown for the specific comparisons
designated. (B and C) Representative traces showing the stimulatory effect of forskolin on DRA activity in HEK293/DRA/CFTR
cells, in the (B) absence and the (C) presence of CFTRinh-172.
648 Tse et al Cellular and Molecular Gastroenterology and Hepatology Vol. 7, No. 3expression suggests that this involves regulation in addition
to changes in trafficking; even considering that only the
higher molecular weight band was involved in increased
surface expression and transport activity.
Intestine is not the only transporting tissue that
expresses CFTR and Cl-/HCO3
- exchangers of the SLC26A
family. Studies in the widely studied human airway cell line
Calu-3 examined mechanisms of cAMP-stimulated HCO3
-
secretion.34 These cells express a large amount of CFTR
and much less SLC26A4 (pendrin). As reported, forskolin-
stimulated HCO3
- secretion in Calu-3 cells was entirely
CFTR-dependent and not affected by SLC26A4 knockdown,
identifying an additional model of cAMP-stimulated HCO3
-
secretion in cells that contain both CFTR and members of the
SLC26 family.34 Of note, pendrin contributed to the forskolin-
stimulated HCO3
- secretion in another Calu-3 study.35
The mechanism by which CFTR is necessary for cAMP
stimulation of DRA activity has not been determined in
human intestinal epithelial cells, including proximal colo-
noids. However, Ko et al35 used nonpolarized HEK293 cells
expressing CFTR and DRA to suggest a mechanism that
involved mutual activation of DRA and CFTR. They showed
in oocytes that CFTR and DRA were in the same complex
(based on coprecipitation), and forskolin-stimulated HCO3
-secretion required DRA activity and was not accounted for
by CFTR transporting HCO3
-.35 cAMP caused DRA and CFTR
to mutually activate each other by a mechanism that
required the presence of both their C-terminal PDZ domain
interaction sequences and involved the cAMP phosphory-
lated CFTR R domain and the DRA sulfate transporter and
anti-sigma factor antagonist (STAS) domain. This activation
of CFTR was not the result of alteration of cAMP stimulation
of its trafficking. Although DRA activity was not explicitly
shown to be required for CFTR activation, mutated DRA
found in congenital Cl- diarrhea did not allow the cAMP
activation of CFTR. Although this has not yet been evaluated
in human proximal colonoids, we hypothesize that the cAMP
stimulation of DRA activity requiring CFTR but not CFTR
transport activity in polarized human intestinal cells is likely
to occur by a mechanism(s) similar to the interactions
shown by Ko et al.35
Our study shows in HEK293/DRA cells, Caco-2 cells, and
human colonoids that forskolin stimulation of DRA is CFTR-
dependent but that dependence does not require CFTR
transport activity. This cAMP stimulation of DRA activity in
human proximal colonoids and Caco-2 cells occurs by a
process that requires CFTR, separate from CFTR transport
activity and different from the interactions identified in
Figure 8. CFTRinh-172 does not affect the stimulatory effect of forskolin on DRA activity in Caco-2 and colonoid
monolayers. In (A–C) Caco-2 monolayers and (D–F) colonoid monolayers, CFTRinh-172 did not change the (B and E) basal
activity of DRA or the (C and F) stimulatory effect of forskolin. The number of experiments is shown as n. P values are shown
for the specific comparisons designated. AP, apical; BL, basolateral.
2019 cAMP Stimulates SLC26A3 Activity 649several other transporting epithelial cells, with multiple
pathophysiologic mechanisms having evolved for cAMP-
related HCO3
- secretion in polarized epithelia. Those
reported vary from HCO3
- secretion entirely via CFTR (Calu-
3 cells) to involving DRA and requiring CFTR protein and
transport activity (mouse duodenum and mid-distal colon).
HCO3
- secretion functions to unfold mucus including that
secreted by goblet cells, which is protective against patho-
gens and inhaled physical agents. From an evolutionary
perspective, HCO3
- secretion has important protective
functions in multiple tissues and thus it is not unexpected




Chemicals and reagents were purchased from Thermo
Fisher (Waltham, MA) or Sigma-Aldrich (St. Louis, MO)unless otherwise specified. All authors had access to the
study data and reviewed and approved the final manuscript.Cell Culture
HEK293 cells were cultured in Dulbecco’s modified
Eagle medium/nutrient mixture F-12 supplemented
with 10% fetal bovine serum, 100 U/mL penicillin, and
100 mg/mL streptomycin in a 5% CO2/95% air atmosphere
at 37C. The plasmid pCMV-SPORT6-SLC26A3 (human) was
purchased from the DNA Resource Core at Harvard Medical
School (Boston, MA). p3xFLAG-DRA was constructed by
inserting human SLC26A3 into p3xFLAG–CMV-10 between
Xba1 and BamHI. A stable cell line that expresses p3xFLAG-
DRA was established using Lipofectamine 2000 according to
the manufacturer’s protocol and selected by G418 exposure.
In some experiments, cells were transfected with N-terminal
green fluorescent protein (GFP)-CFTR (provided by Dr
650 Tse et al Cellular and Molecular Gastroenterology and Hepatology Vol. 7, No. 3Liudmila Cebotaru, Johns Hopkins University) and studied
at 48–72 hours after transfection.
Caco-2 cells were cultured in Dulbecco’s modified
Eagle medium supplemented with 25 mmol/L NaHCO3,
0.1 mmol/L nonessential amino acids, 10% fetal bovine
serum, 4 mmol/L glutamine, 100 U/mL penicillin,
and 100 mg/mL streptomycin in a 5% CO2/95% air atmo-
sphere at 37C. To generate a DRA-KO Caco-2 cell line,
cells were transduced with a lentivirus expressing
doxycycline-inducible Cas9 followed by a lentivirus
expressing a specific green fluorescent protein (sgRNA) that
targets human DRA (GGACTGGGTAACATAGTCTG, NCBI
reference sequence: NM_000111.2). After induction by
doxycycline and selection by puromycin/blasticidin expo-
sure, positive clones were identified by immunoblotting.
Genomic DNA was extracted, the target regions were
amplified by polymerase chain reaction, and sequenced by
Sanger sequencing (Macrogen, Rockville, MD). For experi-
ments, cells were plated on Transwell inserts (Corning, Inc,
Corning, NY) and studied at 14–18 days after reaching
confluency.
Endoscopic specimens of human proximal colon from
healthy human subjects were used to establish primary
cultures of human colonoids as previously described.17,36
Colonoids were expanded and plated on Transwell inserts
(Corning, Inc) to form monolayers, as previously
described.17,18 For differentiation, colonoids were main-
tained in a medium that lacked WNT3A, R-spondin1, and
SB202190 for 5 days.18 Most results of the current study
were obtained from colonoids derived from 1 healthy donor,
with similar results observed in colonoids from 2 other
donors. The procurement and study of human colonoids
was approved by the Institutional Review Board of Johns
Hopkins University School of Medicine (NA_00038329).
Immunofluorescence
Cells were fixed in 4% paraformaldehyde for 20 minutes,
incubated with 5% bovine serum albumin/0.1% saponin in
phosphate-buffered saline for 1 hour, and incubated with
primary antibody against DRA (mouse monoclonal, 1:100,
sc-376187; Santa Cruz, Dallas, TX) overnight at 4C. Cells
then were incubated with Hoechst 33342 and secondary
antibody against mouse IgG (1:100) for 1 hour at room
temperature. Finally, cells were mounted and studied using
a Carl Zeiss LSM510/META confocal microscope (Thorn-
wood, NY). In addition, the atlas of intestinal transport
(https://www.jrturnerlab.com/Transporter-Images) was
accessed to determine the localization of DRA and CFTR in
healthy human proximal colon.
Immunoblotting
Cells were rinsed 3 times with phosphate-buffered saline
and harvested in phosphate-buffered saline by scraping. Cell
pellets were collected by centrifugation, solubilized in lysis
buffer (60 mmol/L HEPES, 150 mmol/L NaCl, 3 mmol/L
KCl, 5 mmol/L EDTA trisodium, 3 mmol/L ethylene
glycol-bis(b-aminoethyl ether)-N,N,N0,N0-tetraacetic acid,1 mmol/L Na3PO4, and 1% Triton X-100, pH 7.4) containing
a protease inhibitor cocktail, and homogenized by sonicat-
ion. Protein concentration was measured using the bicin-
choninic acid method. Proteins were incubated with sodium
dodecyl sulfate buffer (5 mmol/L Tris-HCl, 1% sodium
dodecyl sulfate, 10% glycerol, 1% 2-mercaptoethanol, pH
6.8) at 37C for 10 minutes, separated by sodium dodecyl
sulfate–polyacrylamide gel electrophoresis on a 10%
acrylamide gel, and transferred onto a nitrocellulose mem-
brane. The blot was blocked with 5% nonfat milk, probed
with primary antibodies against DRA (mouse monoclonal,
1:500, sc-376187; Santa Cruz), glyceraldehyde-3-phosphate
dehydrogenase (mouse monoclonal, 1:5000, G8795; Sigma-
Aldrich), b-actin (mouse monoclonal, 1:5000, A2228; Sigma-
Aldrich) overnight at 4C, followed by secondary antibody
against mouse IgG (1:10,000) for 1 hour at room tempera-
ture. Protein bands were visualized and quantitated using
an Odyssey system and Image Studio software (LI-COR
Biosciences, Lincoln, NE).
Surface Biotinylation
At 4C, cells were incubated with 1.5 mg/mL
N-hydroxysulfosuccinimide (NHS)-SS-biotin N-
Hydroxysulfosuccinimide- and solubilized by lysis buffer.
A small proportion of the protein lysate was collected as the
total lysate, while the rest was incubated with avidin-
agarose beads overnight. The beads were centrifuged and
washed with lysis buffer containing 0.1% Triton X-100.
Biotinylated proteins were eluted from the beads and
collected as the surface fraction. Immunoblotting was per-
formed as described earlier and the percentage of surface
expression of DRA was calculated as previously reported by
loading equal volumes for each total and surface fraction.37
The surface to total ratio was calculated separately for the
upper band (highly glycosylated, w102 kilodaltons in size),
the lower band (core glycosylated,w85 kilodaltons in size),




- exchange activity was measured fluorometri-
cally using the pHi-sensitive dye BCECF-AM and a custom
chamber allowing separate apical and basolateral super-
fusion, as previously described.38 Cells were incubated with
10 mmol/L BCECF-AM in Naþ solution (138 mmol/L NaCl,
5 mmol/L KCl, 2 mmol/L CaCl2, 1 mmol/L MgSO4, 1 mmol/L
NaH2PO4, 10 mmol/L glucose, 20 mmol/L HEPES, pH 7.4)
for 30–60 minutes at 37C and mounted in a fluorometer
(Photon Technology International, Birmingham, NJ). Cells
were superfused with Cl- solution (110 mmol/L NaCl,
5 mmol/L KCl, 1 mmol/L CaCl2, 1 mmol/L MgSO4,
10 mmol/L glucose, 25 mmol/L NaHCO3, 1 mmol/L ami-
loride, 5 mmol/L HEPES, 95% O2/5% CO2) or Cl
--free
solution (110 mmol/L Na-gluconate, 5 mmol/L K-gluconate,
5 mmol/L Ca-gluconate, 1 mmol/L Mg-gluconate,
10 mmol/L glucose, 25 mmol/L NaHCO3, 1 mmol/L ami-
loride, 5 mmol/L HEPES, 95% O2/5% CO2) under a flow
rate of 1 mL/min. The switch between Cl- solution and
2019 cAMP Stimulates SLC26A3 Activity 651Cl--free solution causes HCO3
- movement across the cell
membrane performed by Cl-/HCO3
- exchanger(s), and the
resulting change in pHi was recorded. For Caco-2 and
colonoid monolayers, the apical side was superfused with
Cl- solution or Cl--free solution, while the basolateral
side was superfused continuously with Cl- solution. Multiple
rounds of removing/replenishing extracellular Cl- were per-
formed to determine the Cl-/HCO3
- exchange activity under
basal conditions as a time control as well as in the presence
of several compounds, including forskolin (10 mmol/L, api-
cal and basolateral) and CFTRinh-172 (5 mmol/L, apical).
The cells were exposed to these compounds for at least
8 minutes before their effects on Cl-/HCO3
- exchange ac-
tivity was determined. In some experiments, SO4
2- solution
(55 mmol/L Na2SO4, 55 mmol/L mannitol, 5 mmol/L
K-gluconate, 1 mmol/L Ca-gluconate, 1 mmol/L Mg-
gluconate, 10 mmol/L glucose, 25 mmol/L NaHCO3,
2 mmol/L Tenapanor [provided by Ardelyx, Inc, Fremont,
CA], 10 mmol/L HOE-694 [provided by Jorgen Peunter,
Sanofi], 5 mmol/L HEPES, 95% O2/5% CO2) was used to
determine if there was any SO4
2-/HCO3
- exchange. At the
end of each experiment, pHi was calibrated using K
þ clamp
solutions with 10 mmol/L nigericin (Cayman Chemical, Ann
Arbor, MI) that were set at pH 6.8 and 7.6. The rate of initial
alkalinization after the switch from Cl- solution to Cl--free
solution was calculated using Origin 8.0 software (Origin-
Lab, Northampton, MA).Determination of IC50 of DRA Inhibitor
A novel small-molecule DRA inhibitor (DRAinh-A250)
recently was developed by Dr Alan Verkman (University of
California San Francisco, San Francisco, CA).20 After expo-
sure to the inhibitor in both apical and basolateral super-
fusate for at least 15 minutes, the effects of serial
concentrations of the inhibitor (0, 0.1, 0.25, 0.5, 1, 2.5, and
5 mmol/L) on Cl-/HCO3
- exchange activity was studied. The
IC50 was calculated by a logistic regression model using
Origin 8.0 software.Statistical Analysis
The results of at least 3 repeated experiments of HEK293
cells, Caco-2 cells, and colonoids were used for statistical
analysis. Data are presented as means ± SEM. Statistical
analyses were conducted using the Student t test or analysis
of variance if more than 2 comparisons were performed.
P < .05 was considered statistically significant.References
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